A multicenter, double-blind, randomized, placebo-controlled study to evaluate the effects of ezetimibe + simvastatin on clinical outcomes in patients with aortic stenosis.

Trial Profile

A multicenter, double-blind, randomized, placebo-controlled study to evaluate the effects of ezetimibe + simvastatin on clinical outcomes in patients with aortic stenosis.

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Jul 2017

At a glance

  • Drugs Ezetimibe/simvastatin (Primary)
  • Indications Aortic valve stenosis; Atrial fibrillation; Cardiovascular disorders; Heart failure; Ischaemic heart disorders
  • Focus Registrational; Therapeutic Use
  • Acronyms SEAS
  • Sponsors Merck & Co
  • Most Recent Events

    • 11 Jul 2017 Results (n=1725) of post hoc analysis assessing sex differences in risk factors of aortic valve calcification, published in the Heart
    • 28 Apr 2017 Results of association of stroke volume and cardiovascular events (n=1671) published in the Heart
    • 31 Mar 2014 Results of an analysis on the incidence of cataracts presented at the 63rd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top